Shell Asset Management CO Catalyst Pharmaceuticals, Inc. Transaction History
Shell Asset Management CO
- $2.11 Billion
- Q1 2025
A detailed history of Shell Asset Management CO transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 24,351 shares of CPRX stock, worth $617,541. This represents 0.03% of its overall portfolio holdings.
Number of Shares
24,351
Previous 25,363
3.99%
Holding current value
$617,541
Previous $529,000
11.72%
% of portfolio
0.03%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding CPRX
# of Institutions
389Shares Held
99.3MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$474 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$215 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$140 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$86.8 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$79.5 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.61B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...